1. MARKETS
  2. SECTOR : SOFTWARE & SERVICES
  3. INDUSTRY : PACKAGED SOFTWARE
  4. INNOVAGE HOLDING CORP
InnovAge Holding Corp XNAS: INNV
4.14 -0.06 (-1.43%)
128.7K

XNAS 11 Jul, 2025 5:30 PM (EDT)



Insider Trading disclosures for InnovAge Holding Corp

The latest disclosure was made by Patricia Fontneau in InnovAge Holding Corp where a trade of 25,316 Common Stock, $0.001 par value done was reported to US exchanges on July 1, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Patricia Fontneau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 25,316 62,125 - 0 Common Stock, $0.001 par value
Teresa F. Sparks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 25,316 59,126 - 0 Common Stock, $0.001 par value
Richard C. Zoretic Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 25,316 93,810 - 0 Common Stock, $0.001 par value
Marilyn B. Tavenner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 25,316 45,157 - 0 Common Stock, $0.001 par value
John Ellis Bush Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 25,316 45,157 - 0 Common Stock, $0.001 par value
James G. Carlson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 25,316 87,350 - 0 Common Stock, $0.001 par value
Patrick Blair CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.97 per share. 05 Jun 2025 11,880 591,971 - 4.0 47,164 Common Stock, $0.001 par value
Patrick Blair CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.02 per share. 05 Jun 2025 10,088 581,883 - 4.0 40,554 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.96 per share. 04 Jun 2025 15,046 216,568 - 4.0 59,582 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.02 per share. 04 Jun 2025 8,056 208,512 - 4.0 32,385 Common Stock, $0.001 par value
Patrick Blair CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.09 per share. 01 Jun 2025 3,323 603,851 - 4.1 13,591 Common Stock, $0.001 par value
Richard C. Zoretic Director Purchase of securities on an exchange or from another person at price $ 4.04 per share. 28 May 2025 14,265 60,044 - 4.0 57,631 Common Stock, $0.001 par value
Richard C. Zoretic Director Purchase of securities on an exchange or from another person at price $ 4.08 per share. 28 May 2025 8,450 68,494 - 4.1 34,476 Common Stock, $0.001 par value
Richard C. Zoretic Director Purchase of securities on an exchange or from another person at price $ 4.06 per share. 28 May 2025 20,000 45,779 - 4.1 81,200 Common Stock, $0.001 par value
Richard C. Zoretic Director Purchase of securities on an exchange or from another person at price $ 4.09 per share. 21 May 2025 700 24,581 - 4.1 2,863 Common Stock, $0.001 par value
Richard C. Zoretic Director Purchase of securities on an exchange or from another person at price $ 3.93 per share. 21 May 2025 1,198 25,779 - 3.9 4,708 Common Stock, $0.001 par value
Richard C. Zoretic Director Purchase of securities on an exchange or from another person at price $ 4.13 per share. 21 May 2025 1,147 23,881 - 4.1 4,737 Common Stock, $0.001 par value
Richard C. Zoretic Director Purchase of securities on an exchange or from another person at price $ 4.28 per share. 16 May 2025 2,086 21,927 - 4.3 8,928 Common Stock, $0.001 par value
Richard C. Zoretic Director Purchase of securities on an exchange or from another person at price $ 4.20 per share. 16 May 2025 807 22,734 - 4.2 3,389 Common Stock, $0.001 par value
Michael Scarbrough President and COO Purchase of securities on an exchange or from another person at price $ 3.89 per share. 09 May 2025 10,000 33,000 - 3.9 38,900 Common Stock, $0.001 par value
Michael Scarbrough President and COO Purchase of securities on an exchange or from another person at price $ 3.73 per share. 09 May 2025 13,000 23,000 - 3.7 48,490 Common Stock, $0.001 par value
Michael Scarbrough President and COO Purchase of securities on an exchange or from another person at price $ 3.55 per share. 09 May 2025 10,000 10,000 - 3.6 35,500 Common Stock, $0.001 par value
Patrick Blair CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. 01 Mar 2025 3,807 607,174 - 3.3 12,373 Common Stock, $0.001 par value
Patrick Blair CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.87 per share. 01 Dec 2024 5,053 610,981 - 4.9 24,608 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 6.54 per share. 06 Nov 2024 1,660 231,614 - 6.5 10,856 Common Stock, $0.001 par value
Nicole Damato Chief Legal Officer Sale of securities on an exchange or to another person at price $ 6.00 per share. 16 Sep 2024 7,521 233,274 - 6 45,126 Common Stock, $0.001 par value
Nicole Damato Chief Legal Officer Sale of securities on an exchange or to another person at price $ 5.95 per share. 16 Sep 2024 4,372 240,795 - 5.9 26,013 Common Stock, $0.001 par value
Richard C. Zoretic Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2024 19,841 19,841 - 0 Common Stock, $0.001 par value
Marilyn B. Tavenner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2024 19,841 19,841 - 0 Common Stock, $0.001 par value
John Ellis Bush Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2024 19,841 19,841 - 0 Common Stock, $0.001 par value
James G. Carlson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2024 13,334 62,034 - 0 Common Stock, $0.001 par value
James G. Carlson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2024 20,161 48,700 - 0 Common Stock, $0.001 par value
Teresa F. Sparks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2024 16,448 33,810 - 0 Common Stock, $0.001 par value
Patricia Fontneau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2024 22,523 36,809 - 0 Common Stock, $0.001 par value
Patrick Blair PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.36 per share. 01 Sep 2024 5,053 616,034 - 6.4 32,137 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.22 per share. 15 Aug 2024 14,303 245,167 - 6.2 88,965 Common Stock, $0.001 par value
Richard A. Feifer CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.22 per share. 15 Aug 2024 14,303 220,908 - 6.2 88,965 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.03 per share. 02 Jul 2024 7,486 259,470 - 5.0 37,655 Common Stock, $0.001 par value
Christine Bent CHIEF OPERATIONS OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.83 per share. 06 Jun 2024 10,187 201,955 - 4.8 49,203 Common Stock, $0.001 par value
Patrick Blair PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.83 per share. 06 Jun 2024 10,088 621,087 - 4.8 48,725 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.83 per share. 06 Jun 2024 8,056 266,956 - 4.8 38,910 Common Stock, $0.001 par value
Richard A. Feifer CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.83 per share. 06 Jun 2024 8,023 235,211 - 4.8 38,751 Common Stock, $0.001 par value
Patrick Blair PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 123,967 631,175 - 0 Common Stock, $0.001 par value
Christine Bent CHIEF OPERATIONS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 86,581 212,142 - 0 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 97,403 275,012 - 0 Common Stock, $0.001 par value
Richard A. Feifer CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 108,226 243,234 - 0 Common Stock, $0.001 par value
Patrick Blair PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.44 per share. 01 Jun 2024 3,321 507,208 - 4.4 14,745 Common Stock, $0.001 par value
Christine Bent CHIEF OPERATIONS OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. 17 Apr 2024 8,734 125,561 - 4 34,936 Common Stock, $0.001 par value
Patrick Blair PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.87 per share. 01 Mar 2024 3,566 510,529 - 4.9 17,366 Common Stock, $0.001 par value
Blair Patrick PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.90 per share. 01 Dec 2023 3,322 514,095 - 5.9 19,600 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. 15 Aug 2023 9,673 177,609 - 5.6 54,169 Common Stock, $0.001 par value
Richard A. Feifer CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. 15 Aug 2023 9,737 135,008 - 5.6 54,527 Common Stock, $0.001 par value
Teresa F. Sparks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2023 17,362 17,362 - 0 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 7.12 per share. 17 Jul 2023 4,000 187,282 - 7.1 28,480 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 7.07 per share. 17 Jul 2023 1,866 191,282 - 7.1 13,193 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 7.07 per share. 13 Jul 2023 3,448 193,148 - 7.1 24,377 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 7.06 per share. 11 Jul 2023 892 197,007 - 7.1 6,298 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 7.08 per share. 11 Jul 2023 411 196,596 - 7.1 2,910 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 7.01 per share. 06 Jul 2023 139 204,321 - 7.0 974 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 7.10 per share. 06 Jul 2023 6,422 197,899 - 7.1 45,596 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 7.28 per share. 02 Jul 2023 4,173 204,460 - 7.3 30,379 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Sale of securities on an exchange or to another person at price $ 7.26 per share. 02 Jul 2023 2,101 208,633 - 7.3 15,253 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. 02 Jul 2023 20,220 210,734 - 7.5 151,650 Common Stock, $0.001 par value
Patrick Blair President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.73 per share. 01 Jun 2023 3,321 416,896 - 6.7 22,350 Common Stock, $0.001 par value
Patricia Fontneau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2023 14,286 14,286 - 0 Common Stock, $0.001 par value
Christine Bent CHIEF OPERATIONS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2023 82,143 82,143 - 0 Common Stock, $0.001 par value
Patrick Blair President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. 11 Apr 2023 3,320 420,217 - 7.7 25,564 Common Stock, $0.001 par value
Patrick Blair President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.20 per share. 01 Dec 2022 20,062 423,537 - 7.2 144,446 Common Stock, $0.001 par value
Thomas A. Scully Director Purchase of securities on an exchange or from another person at price $ 5.10 per share. 15 Sep 2022 100,000 100,000 - 5.1 509,800 Common Stock, $0.001 par value
Richard A. Feifer CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2022 92,593 92,593 - 0 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2022 92,593 178,802 - 0 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.45 per share. 02 Jul 2022 10,707 86,209 - 4.4 47,646 Common Stock, $0.001 par value
James G. Carlson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 28,539 28,539 - 0 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 33,250 58,130 - 0 Common Stock, $0.001 par value
Nicole Damato CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 38,786 96,916 - 0 Common Stock, $0.001 par value
Robin Doerr Chief Sales and MKTG Officer Purchase of securities on an exchange or from another person at price $ 25.74 per share. 15 Mar 2021 1,875 1,875 - 25.7 48,263 Common Stock, $0.001 Par value
Maureen Hewitt Director, CEO, President and Director Purchase of securities on an exchange or from another person at price $ 26.62 per share. 12 Mar 2021 9,350 9,350 - 26.6 248,897 Common Stock, $0.001 Par value
Barbara Gutierrez Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 26.43 per share. 12 Mar 2021 2,000 2,000 - 26.4 52,860 Common Stock, $0.001 Par value
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures